Search results
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 16 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 10 hours agoBoth experts caution that, anytime you’re spending time in crowded places, there’s still some risk...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 19 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax ...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 4 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 6 days agovaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 6 days agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 days agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 2 days agoAround 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by...